Friday, December 1, 2023
The AGA Institute requires every individual in a position to control educational content to disclose all financial relationships with ineligible companies that have occurred within the past 24 months. Ineligible companies are organizations whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients. All relevant financial relationships for anyone with the ability to control the content of this educational activity are listed below and have been mitigated. Others involved in the planning of this activity have no relevant financial relationships.
Professor of Medicine
Division of Gastroenterology and Hepatology
Director, Inflammatory Bowel Disease Program
Director, Digestive Health Center
University of Maryland School of Medicine
Baltimore, Maryland
Associate Professor of Medicine
Division of Gastroenterology and Hepatology
Associate Dean for Medical School Admissions
Associate Dean for Faculty Diversity and Inclusion
University of Maryland School of Medicine
Baltimore, Maryland
Associate Professor of Medicine
Harvard Medical School
Director, Crohn’s and Colitis Center
Director, Fecal Microbiota Transplant Program
Brigham & Women’s Hospital
Boston, Massachusetts
This activity has been peer reviewed and the reviewer has no relevant financial relationships.
Physicians - maximum of 1.00 AMA PRA Category 1 Credit(s)™
This activity is intended for gastroenterologists, primary care physicians, obstetricians/gynecologists, physician assistants, nurses, and nurse practitioners.
The goal of this activity is for learners to be better able to incorporate new targeted treatments for IBD into practice, including individualizing treatment.
Upon completion of this activity, participants will:
The AGA Institute requires every individual in a position to control educational content to disclose all financial relationships with ineligible companies that have occurred within the past 24 months. Ineligible companies are organizations whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients. All relevant financial relationships for anyone with the ability to control the content of this educational activity are listed below and have been mitigated. Others involved in the planning of this activity have no relevant financial relationships.
Professor of Medicine
Division of Gastroenterology and Hepatology
Director, Inflammatory Bowel Disease Program
Director, Digestive Health Center
University of Maryland School of Medicine
Baltimore, Maryland
Associate Professor of Medicine
Division of Gastroenterology and Hepatology
Associate Dean for Medical School Admissions
Associate Dean for Faculty Diversity and Inclusion
University of Maryland School of Medicine
Baltimore, Maryland
Associate Professor of Medicine
Harvard Medical School
Director, Crohn’s and Colitis Center
Director, Fecal Microbiota Transplant Program
Brigham & Women’s Hospital
Boston, Massachusetts
This activity has been peer reviewed and the reviewer has no relevant financial relationships.
Developed through a partnership between Medscape and American Gastroenterological Association.
The AGA Institute is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
The AGA Institute designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credits ™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
For questions regarding the content of this activity, contact the accredited provider for this CME/CE activity noted above. For technical assistance, contact [email protected]
There are no fees for participating in or receiving credit for this online educational activity. For information on applicability
and acceptance of continuing education credit for this activity, please consult your professional licensing board.
This activity is designed to be completed within the time designated on the title page; physicians should claim only those
credits that reflect the time actually spent in the activity. To successfully earn credit, participants must complete the
activity online during the valid credit period that is noted on the title page. To receive AMA PRA Category 1 Credit™, you must receive a minimum score of 75% on the post-test.
Follow these steps to earn CME/CE credit*:
You may now view or print the certificate from your CME/CE Tracker. You may print the certificate, but you cannot alter it.
Credits will be tallied in your CME/CE Tracker and archived for 6 years; at any point within this time period, you can print
out the tally as well as the certificates from the CME/CE Tracker.
*The credit that you receive is based on your user profile.
CME Released: 5/31/2023
Valid for credit through: 5/31/2024, 11:59 PM EST
processing....
The goal of this activity is for learners to be better able to incorporate new targeted treatments for IBD into practice, including individualizing treatment.
Before you begin this activity, please assess your clinical knowledge by completing this brief survey. Answering these questions again after the activity will allow you to see what you learned and to compare your answers with those of your peers.
